Onconano Medicine

Dallas, United States

OncoNano Medicine is a biotech company that develops pH-activated compounds that digitalize and exploit the variability of pH in disease.

$18.4M raised

Oct 2021

Series B

Biotechnology Health Care Nanotechnology Therapeutics

Top Investors

Cancer Prevention and Research Institute of Texas Salem Partners Advantech Capital Adam Okun

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Onconano Medicine

How much funding has Onconano Medicine raised?

Onconano Medicine has raised $18.4M in total funding. The most recent round was Series B. The last funding was announced in October 2021.

Who are Onconano Medicine's investors?

Onconano Medicine's investors include Cancer Prevention and Research Institute of Texas, Salem Partners, Advantech Capital, Adam Okun.

Where is Onconano Medicine headquartered?

Onconano Medicine is headquartered in Dallas, United States.

What does Onconano Medicine do?

OncoNano Medicine is a biotech company that develops pH-activated compounds that digitalize and exploit the variability of pH in disease.

What stage is Onconano Medicine at?

Onconano Medicine is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 25, 2021.

MLA

"Onconano Medicine — Funding & Investors." VCBacked, October 25, 2021, https://www.vcbacked.co/company/onconano-medicine. Accessed July 3, 2026.

APA

VCBacked. (2021). Onconano Medicine — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/onconano-medicine

Wikipedia (cite web)

{{cite web |title=Onconano Medicine — Funding & Investors |url=https://www.vcbacked.co/company/onconano-medicine |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 25, 2021.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K